DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 78 filers reported holding DERMIRA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $5,919,000 | -24.7% | 175,000 | -34.9% | 0.55% | -42.6% |
Q2 2016 | $7,865,000 | +474.9% | 268,878 | +245.1% | 0.95% | +882.5% |
Q2 2015 | $1,368,000 | +29.1% | 77,915 | +12.8% | 0.10% | +14.1% |
Q1 2015 | $1,060,000 | +41.0% | 69,069 | +66.3% | 0.08% | +63.5% |
Q4 2014 | $752,000 | – | 41,533 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
Jeneq Management LP | 96,570 | $923,000 | 0.82% |
Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |